Since various mutations in BRCA1 have been identified in several cancers, including breast, ovarian, and lymphoid cancers34, we hypothesized that downregulation of or mutations in BRCA1 would induce leukemia through dysregulation of NSD2 during myeloid cell differentiation. This evidence concerns the gene BRCA1 and cancer.